1 month Pfizer (NYSE:PFE) Earns Overweight Rating from Cantor FitzgeraldMarketBeat
Cantor Fitzgerald restated an “overweight” rating and issued a $45.00 price target on shares of Pfizer in a research note on Wednesday.
NYSE · Pfizer (PFE) · Science
X